Oxford Cancer Analytics
Oxford, United Kingdom · Founded 2020
- Headquarters
- Oxford
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- oxcan.org
- Last Round
- Series AJan 2025
- Rounds
- 2
About
Enabling Curative Cancer Treatment Through Early Detection- Focused on Lung Cancer
Summary
Oxford Cancer Analytics is a Healthcare company based in Oxford, United Kingdom, founded in 2020. Its most recent funding was a Series A round in Jan 2025. Investors include Eka Ventures, Cross-Border Impact Ventures and We Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Global contract research organization providing comprehensive drug development and laboratory ser...